SIGY · Sigyn Therapeutics, Inc.
$0.03
0.00 (-16.39%)
At close · Jul 28
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“These matters raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 14, 2025
Market Cap
$40,134
Shares
1.61M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$143.32K
+405.6%
FY2019
Net Income
-$3.34M
+19.4%
FY2024
Gross Margin
75.12%
+9.4pp
FY2019
Operating Margin
-361.39%
+3182.8pp
FY2019
Diluted EPS
-$2.51
+33.4%
FY2024
Operating Cash Flow
-$872.44K
+36.9%
FY2024
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $10.69K | — | — | — | — | — | $143.32K | $28.35K | $38.43K | $29.21K | $43.15K | |
| $3900 | — | — | — | — | — | $35.67K | $9712 | $21.43K | $9930 | $25.25K | |
| $6785 | — | — | — | — | — | $107.66K | $18.64K | $17K | $19.28K | $17.9K | |
| — | — | — | — | — | — | 75.12% | 65.74% | 44.24% | 66% | 41.49% | |
| $140.1K | $773.28K | $798.17K | $657.66K | $734.01K | $419.36K | — | — | — | — | — | |
| $1.7M | $1.74M | $1.66M | $1.49M | $1.27M | $496.37K | $613.78K | $862.41K | $1.05M | $833.55K | $399.88K | |
| — | — | $2100 | $3600 | $16.21K | $10.95K | — | — | — | — | — | |
| $1.88M | $2.52M | $2.46M | $2.15M | $2.01M | $916.43K | $625.62K | $1.02M | $2.05M | $2.27M | $405.45K | |
| -$1.88M | -$2.52M | -$2.46M | -$2.15M | -$2.01M | -$916.43K | -$517.96K | -$1M | -$2.03M | -$2.25M | -$387.54K | |
| — | — | — | — | — | — | -361.39% | -3544.18% | -5277.41% | -7714.35% | -898.05% | |
| $307.21K | — | — | — | — | $343.16K | $55.2K | $352.84K | $790.84K | -$441.18K | — | |
| -$1.34M | -$820.97K | -$1.69M | -$782.55K | -$996.4K | -$343.16K | -$2.8M | -$1.3M | -$1.82M | $441.18K | — | |
| -$3.22M | -$3.34M | -$4.15M | -$2.93M | -$3M | -$1.26M | -$3.31M | -$2.3M | -$3.84M | -$2.69M | -$387.54K | |
| — | — | — | — | — | — | — | $800 | $800 | — | — | |
| -$3.22M | -$3.34M | -$4.15M | -$2.93M | -$3M | -$1.26M | -$3.07M | -$2.62M | -$4.25M | -$2.69M | -$387.54K | |
| — | — | — | — | — | — | -2145.3% | -9243.24% | -11061.21% | -9224.88% | -898.05% | |
| USD/shares | — | -$2.51 | -$3.77 | -$3.13 | -$3.20 | — | — | — | — | — | — |
| USD/shares | — | -$2.51 | -$3.77 | -$3.13 | — | — | — | — | — | — | — |
| shares | — | 1.33M | 1.1M | 934.92K | 909.91K | 183.78K | 2.03M | 1.63M | 1.18M | 774.82K | 698.8K |
| shares | — | 1.33M | 1.1M | 934.92K | 909.91K | 183.78K | 2.03M | 1.63M | 1.18M | 774.82K | 698.8K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.